FIELD: medicine, cardiology. SUBSTANCE: method deals with applying thymogen at 3.58-1.79 mcg/kg intravenously before induced ischemia is available. EFFECT: decreased number of complications due to ischemia and reperfusion lesions. 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF HEARTBEAT RECOVERY FOLLOWING DIASTOLIC ARREST IN EXPERIMENT | 2010 |
|
RU2424582C1 |
| ANTIISCHEMICALLY-ACTIVE AGENT | 1988 |
|
RU2007985C1 |
| METHOD OF ARRHYTHMIA PREVENTION IN EXPERIMENT | 1993 |
|
RU2076719C1 |
| METHOD FOR RESTORING HEART CONTRACTILITY AFTER CARDIOPLEGIA WITH CALCIUM ANTAGONISTS IN EXPERIMENT | 1996 |
|
RU2133612C1 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| AGENT FOR INCREASING RESISTANCE OF HEART TO ARRYTHMOGENIC ACTION OF ISCHAEMIA AND REPERFUSION | 2014 |
|
RU2587783C1 |
| METHOD FOR DIAGNOSING OPENING OF THE CORONARY ARTERY IN ACUTE MYOCARDIAL INFARCTION PATIENTS | 1999 |
|
RU2189173C2 |
| "INFUSOL" CARDIOPLEGIC SOLUTION | 2002 |
|
RU2226093C1 |
| METHOD FOR PRECONDITIONING MYOCARDIUM | 2006 |
|
RU2312691C1 |
| CRYSTALLOID CARDIOPLEGIC SOLUTION | 2009 |
|
RU2423135C2 |
Authors
Dates
1997-07-10—Published
1993-12-22—Filed